Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · IEX Real-Time Price · USD
231.01
-3.18 (-1.36%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Inspire Medical Systems Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for INSP stock have an average target of 276.87, with a low estimate of 159 and a high estimate of 371. The average target predicts an increase of 19.85% from the current stock price of 231.01.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for INSP stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 5 | 5 | 5 | 5 |
| Buy | 6 | 5 | 5 | 6 | 6 | 7 |
| Hold | 1 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 13 | 14 | 14 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Initiates $285 | Buy | Initiates | $285 | +23.37% | Apr 19, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $250 | Strong Buy | Maintains | $250 | +8.22% | Mar 27, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $280 | Strong Buy | Reiterates | $280 | +21.21% | Mar 20, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $250 | Buy | Initiates | $250 | +8.22% | Mar 19, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $265 → $280 | Strong Buy | Maintains | $265 → $280 | +21.21% | Feb 7, 2024 |
Financial Forecast
Revenue This Year
797.92M
from 624.80M
Increased by 27.71%
Revenue Next Year
969.93M
from 797.92M
Increased by 21.56%
EPS This Year
-0.37
from -0.72
EPS Next Year
0.63
from -0.37
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 835.9M | 1.0B | 1.2B | 1.4B | 1.6B |
| Avg | 797.9M | 969.9M | 1.2B | 1.3B | 1.5B |
| Low | 759.5M | 881.6M | 1.0B | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 33.8% | 31.2% | 28.3% | 21.9% | 25.7% |
| Avg | 27.7% | 21.6% | 20.0% | 12.7% | 15.2% |
| Low | 21.6% | 10.5% | 7.7% | 1.5% | 2.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.22 | 2.53 | 5.44 | 4.29 | 5.74 |
| Avg | -0.37 | 0.63 | 2.16 | 3.58 | 4.88 |
| Low | -1.15 | -0.32 | 0.62 | 2.98 | 4.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 758.4% | 98.6% | 60.3% |
| Avg | - | - | 241.3% | 65.7% | 36.1% |
| Low | - | - | -2.6% | 37.8% | 11.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.